New Mesothelioma Drug Kills Cancer Stem Cells – Surviving Mesothelioma
| Surviving Mesothelioma Massachusetts-based Verastem, Inc. focuses on drugs that fight cancer by attacking the stem cells that give rise to them. Earlier this summer, the FDA granted orphan drug status to their stem cell inhibitor, defactinib, for the treatment of mesothelioma. |
